Omnicell (OMCL) Net Cash Flow Growth (1y) (2011 - 2026)
Omnicell (OMCL) Net Cash Flow Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 32.90 Bn | 25.59 Bn | 662.02 Mn | -43.71% |
| 2 | Healthequity | 8.58 Bn | 8.31 Bn | 256.31 Mn | -564.99% |
| 3 | 10x Genomics | 6.00 Bn | 5.46 Bn | 106.18 Mn | -50.15% |
| 4 | Hinge Health | 5.92 Bn | 5.61 Bn | 154.23 Mn | -76.26% |
| 5 | MiniMed | 4.60 Bn | 4.31 Bn | 480.00 Mn | 28,500.00% |
| 6 | Waystar Holding | 4.55 Bn | 4.49 Bn | 216.84 Mn | -131.26% |
| 7 | Doximity | 4.00 Bn | 3.25 Bn | 125.97 Mn | 248.05% |
| 8 | Privia Health | 3.08 Bn | 2.66 Bn | - | -175.74% |
| 9 | Omnicell | 1.94 Bn | 1.70 Bn | 140.36 Mn | 188.43% |
| 10 | Teladoc Health | 1.67 Bn | 918.68 Mn | 416.32 Mn | 72.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 188.43% |
| Dec 31, 2025 | 113.06% |
| Sep 30, 2025 | -1,688.00% |
| Jun 30, 2025 | -46.14% |
| Mar 31, 2025 | -71.29% |
| Dec 31, 2024 | -589.34% |
| Sep 30, 2024 | -71.58% |
| Jun 30, 2024 | -53.76% |
| Mar 31, 2024 | 1,555.72% |
| Dec 31, 2023 | -42.78% |
| Sep 30, 2023 | 217.77% |
| Jun 30, 2023 | 446.18% |
| Mar 31, 2023 | 104.48% |
| Dec 31, 2022 | 154.30% |
| Sep 30, 2022 | 110.85% |
| Jun 30, 2022 | -127.32% |
| Mar 31, 2022 | -211.63% |
| Dec 31, 2021 | 9.84% |
| Sep 30, 2021 | -126.74% |
| Jun 30, 2021 | 120.96% |